Steinhart Richard I
SEC-identified person · CIK 1293789 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Bioxcel Therapeutics, Inc. BTAI ] | Senior VP and CFO | filed 2018 - 2026 |
| Atossa Therapeutics, INC. ATOS | Director | filed 2014 - 2026 |
| Cactus Ventures, Inc. none | Director | filed 2013 - 2025 |
| Strata Skin Sciences, Inc. SSKN | Chief Financial Officer | filed 2006 - 2013 |
| TG Therapeutics, INC. TGTXD | Director | filed 2007 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.